European journal of obstetrics, gynecology, and reproductive biology · 2004
Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suh JiHyun, Lee EunYoung, Hwang SeongSoo, Yoon Sarah, Yoon Byung Koo, Bae DukSoo, Choi DooSeok
Аннотация
OBJECTIVE: To determine the effect of dose of GnRH agonist on the follicular environment in controlled ovarian hyperstimulation (COH) cycles.
STUDY DESIGN: Twenty-eight IVF patients with normal ovarian function were divided into three groups: group I received GnRHa (nafarelin acetate/Synarel) intranasally at 200 microg daily, group II received 400 microg daily until hCG injection, and group III was given 400 microg daily before the initiation of ovarian stimulation, then 200 microg daily before the day of hCG injection. Serum estradiol, progesterone, and leptin levels were measured on the day of hCG injection. After aspiration, expression of pregnancy-associated alpha-plasma protein (PAPP)-A in the follicular fluid of dominant follicles (>20 mm) was determined by Western blot analysis.
RESULTS: No significant difference was noted in serum estradiol, progesterone, and leptin levels. But intrafollicular PAPP-A expression was significantly higher in group II compared to other groups (P<0.05).
CONCLUSION: The dose of GnRHa may have an impact on the intrafollicular environment of dominant follicles in COH cycles.
STUDY DESIGN: Twenty-eight IVF patients with normal ovarian function were divided into three groups: group I received GnRHa (nafarelin acetate/Synarel) intranasally at 200 microg daily, group II received 400 microg daily until hCG injection, and group III was given 400 microg daily before the initiation of ovarian stimulation, then 200 microg daily before the day of hCG injection. Serum estradiol, progesterone, and leptin levels were measured on the day of hCG injection. After aspiration, expression of pregnancy-associated alpha-plasma protein (PAPP)-A in the follicular fluid of dominant follicles (>20 mm) was determined by Western blot analysis.
RESULTS: No significant difference was noted in serum estradiol, progesterone, and leptin levels. But intrafollicular PAPP-A expression was significantly higher in group II compared to other groups (P<0.05).
CONCLUSION: The dose of GnRHa may have an impact on the intrafollicular environment of dominant follicles in COH cycles.
Предметные рубрики MeSH
Administration, IntranasalAdultBlotting, WesternDose-Response Relationship, DrugDrug Administration ScheduleEstradiolFemaleFollow-Up StudiesHumansInfertility, FemaleLeptinMenstrual CycleNafarelinOvulation InductionPregnancy-Associated Plasma Protein-AProbabilityProgesteroneProspective StudiesRadioimmunoassayRisk AssessmentStatistics, Nonparametric